Spots Global Cancer Trial Database for OVATURE (OVArian TUmor REsponse) A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: OVATURE (OVArian TUmor REsponse) A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer
Official Title: Multi-Center, Randomized, Double-Blind, Phase III Efficacy Study Comparing Phenoxodiol in Combination With Carboplatin Versus Carboplatin With Placebo in Patients With Platinum-Resistant or Platinum-Refractory Late-Stage Epithelial Ovarian, Fallopian or Primary Peritoneal Cancer Following at Least Second Line Platinum Therapy
Study ID: NCT00382811
Study Description
Brief Summary: The purpose of this project is to see if weekly carboplatin compared with phenoxodiol in combination with weekly carboplatin, is effective against late stage ovarian cancer and to see what, if any, side-effects of treatment may result.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Arizona Clinical Research Center, Inc., Tuscon, Arizona, United States
Glendale Adventist, Glendale, California, United States
Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, United States
Cedars-Sinai Medical Center, Los Angeles, California, United States
Gynecology Oncology Associates, Newport Beach, California, United States
Yale University School of Medicine, New Haven, Connecticut, United States
Hematology Oncology, PC (Carl and Dorothy Bennett Cancer Center), Stamford, Connecticut, United States
Gynecologic Oncology Associates, Pembroke Pines, Florida, United States
Piedmont Hospital, Atlanta, Georgia, United States
Medical College of Georgia Cancer Center, Augusta, Georgia, United States
Associates in Women's Health, Wichita, Kansas, United States
Hematology and Oncology Specialists, LLC, Metairie, Louisiana, United States
Greater Baltimore Medical Centre, Baltimore, Maryland, United States
Gynecologic Oncology of West Michigan, Grand Rapids, Michigan, United States
Providence Hospital and Medical Centers, Southfield, Michigan, United States
The Center for Cancer & Hematological Disease, Cherry Hill, New Jersey, United States
Jersey Shore Medical Center, Neptune, New Jersey, United States
The University of New Mexico Cancer Research and Treatment Center, Albuquerque, New Mexico, United States
Schwartz Gynecologic Oncology, Brightwaters, New York, United States
New York Downtown Hospital, New York, New York, United States
University of Rochester Gynecologic Oncology Associates, Rochester, New York, United States
Carolinas Medical Center, Charlotte, North Carolina, United States
Brody School of Medical at East Carolina University, Greenville, North Carolina, United States
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States
Gabrail Cancer Center, Canton, Ohio, United States
MetroHealth Medical Center, Cleveland, Ohio, United States
OSU James Cancer Hospital & Solove Research Institute, Columbus, Ohio, United States
Miami Valley Hospital, Dayton, Ohio, United States
Chattanooga GYN Oncology, Chattanooga, Tennessee, United States
Chattanooga's Program In Women's Oncology, Chattanooga, Tennessee, United States
Hall and Martin MDS, P.C., Knoxville, Tennessee, United States
Sarah Cannon Research Institute, Nashville, Tennessee, United States
Hope Cancer Clinic, Brownsville, Texas, United States
University of Texas Southwestern Medical Center Simmons Comprehensive Cancer Center, Dallas, Texas, United States
Baylor College of Medicine, Houston, Texas, United States
Northern Virginia Pelvic Surgery Associates, Annadale, Virginia, United States
Virginia Mason Medical Center Department of Hematology/Oncology, Seattle, Washington, United States
Prince of Wales Hospital, Randwick, New South Wales, Australia
Royal North Shore Hospital, Sydney, New South Wales, Australia
Westmead Hospital, Westmead, New South Wales, Australia
Mater Adult Hospital, Brisbane, Queensland, Australia
Royal Adelaide Hospital, Adelaide, South Australia, Australia
UZ Antwerpen, Edegem, , Belgium
UZ Leuven, Leuven, , Belgium
IEO- Istituto Europeo di Oncologia, Milano, , Italy
Istitutio Fisioterapici Ospitaleri, Roma, , Italy
Bialostockie Centrum Onkologii im. Marii Sklodowskiej-Curie Oddzial Onkologii Ginekologicznej, Bialystok, , Poland
Ackademickie Centrum Kliniczne-Szpital, Akademii Medycznej w Gdansku, Gdansk, , Poland
Centrum Onkologii-Instytut im. M. Sklodowskiej-Curie, Oddzial w Gliwicach, Gliwice, , Poland
Centrum Onkologii - Instytut im. M. Sklodowskiej-Curie Oddzial w Krakowie Klinika Ginekologii Onkologicznej, Krakow, , Poland
Centrum Onkologii Ziemi, Lublin, , Poland
Ginekologiczno - Polozniczy Szpital Kliniczny AM im. K. Marcinkowskiego w Poznaniu SPZOZ Klinika Onkologii Ginekologicznej, Poznan, , Poland
Centrum Onkologii-Instytut im. M. Sklodowskiej Curie Klinika Nowotworow Narzadow Plciowych Kobiecych, Warszawa, , Poland
Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain
Hospital General Universitario de Alicante, Alicante, , Spain
Hospital del Mar, Barcelona, , Spain
Hospital General Vall d'Hebron, Barcelona, , Spain
Hospital Clinic i Provincial de Barcelona, Barcelona, , Spain
Hospital General Universitario de Valencia, Valencia, , Spain
Yeovil District Hospital, Yeovil, Somerset, United Kingdom
Cancer Research UK Clinical Trials Unit Old Clinical Investigations Building, Birmingham, , United Kingdom
Ninewells Hospital, Dundee, , United Kingdom
Edinburgh Cancer Research Centre Western General Hospital, Edinburgh, , United Kingdom
The Beatson West of Scotland Cancer Centre, Glasgow, , United Kingdom
St James University Hospital, Leeds, , United Kingdom
Hammersmith Hospital, London, , United Kingdom
Cancer Research UK & UCL Cancer Trials Center, London, , United Kingdom
Nottingham University Hospitals NHS Trust, Nottingham, , United Kingdom
Royal Marsden NHS Foundation Trust, Sutton, , United Kingdom
Clatterbridge Centre for Oncology, Wirral, , United Kingdom
Contact Details
Name: Daniel P Gold, PhD
Affiliation: MEI Pharma, Inc.
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
